Nuveen Securitized Income (NSCI) ETF Holdings & Analysis
ETFOther
Track NSCI in your portfolio for free · Portfolio tracker
What NSCI does
This actively managed approach seeks to generate compelling returns, optimized for the level of risk taken, by strategically investing in a diverse collection of structured credit products.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| CAS 2023-R VRN 09/25/2043 | 1.53% | |
| ARDN 2025- VRN 06/15/2035 | 1.12% | |
| JPMMT 2025 VRN 05/25/2056 | 1.07% | |
| STATE STREET INSTITUTION | 1.03% | |
| NYCT 2024- VRN 08/15/2029 | 0.99% | |
| STACR 2026 VRN 09/25/2046 | 0.96% | |
| LITPK 2025 VRN 10/24/37 | 0.96% | |
| AIMCO 2022 VRN 07/20/2039 | 0.96% | |
| VERUS 2026 VRN 09/25/2071 | 0.94% | |
| JPMMT 2026 VRN 12/01/2066 | 0.94% |
PortView Portfolio Insights
PortView analyzes how NSCI fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NSCI in PortView →Related securities
Related stocks
Frequently asked questions
- What does NSCI track?
- NSCI is the Nuveen Securitized Income, a Other ETF.
- What is the expense ratio of NSCI?
- Expense ratio data for NSCI is shown on the page when available from our data provider.
- What are the largest holdings in NSCI?
- Top holdings include CAS 2023-R VRN 09/25/2043, ARDN 2025- VRN 06/15/2035, JPMMT 2025 VRN 05/25/2056, GVMXX, NYCT 2024- VRN 08/15/2029.
- How can PortView analyze NSCI overlap with other ETFs?
- PortView computes the holdings overlap between NSCI and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.